Skip to main content
Signal8

Walters-Hoffert Lisa

SEC insider (Form 3/4/5 filer). CIK 0001711576. Director at KIORA PHARMACEUTICALS INC (KPRX) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in VISTA, CA.

Companies Walters-Hoffert Lisa has filed insider reports for

  • KIORA PHARMACEUTICALS INC (KPRX): Director
  • Flux Power Holdings, Inc. (FLUX): Director
Walters-Hoffert Lisa profile photo

Walters-Hoffert Lisa

CIK: 0001711576

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (40.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

KIORA PHARMACEUTICALS INC logo
KPRX

KIORA PHARMACEUTICALS INC

Director
Flux Power Holdings, Inc. logo
FLUX

Flux Power Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Jun 10, 2026
    Award

    Stock Option (right to buy)

    Direct
    25K shares-
  • Flux Power Holdings, Inc. logo
    FLUX

    Flux Power Holdings, Inc.

    May 28, 2026
    Exercise
    Direct
    50K shares-
  • Flux Power Holdings, Inc. logo
    FLUX

    Flux Power Holdings, Inc.

    May 28, 2025
    Award

    Restricted Stock Units

    Direct
    50K shares-
  • Flux Power Holdings, Inc. logo
    FLUX

    Flux Power Holdings, Inc.

    Apr 18, 2025
    Exercise
    Direct
    17.1K shares-
  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Apr 1, 2025
    Award

    Stock Option (right to buy)

    Direct
    20K shares-

1-5 of 5